Delivery Order SPE2DB22D2206-SPE2DB25FFD89

Award Date 1/17/25
Potential Completion Date 2/10/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,547.42 firm fixed-price delivery order is for the supply of TABRECTA 200 MG TABLET (National Drug Code 4566554061) with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $6,547.42 firm fixed-price delivery order covers the supply of TABRECTA 200 MG TABLET, a pharmaceutical product, to support government healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive...
This Federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,428.06, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with an identifier of SPE2DB24D3013|SPE2DB25FFJWN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $14,428.06, is a delivery order contract with a firm fixed price pricing type. The contract is for the supply of TABRECTA 200 MG TABLET UU 56S, which are likely pharmaceutical products. The award has an ultimate completion date of March 24, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,094.84 firm fixed-price delivery order is for the supply of 4566306589 TABRECTA 200 MG TABLET UU 56S, with a completion date of November 25, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of TABRECTA 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $13,094.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TABRECTA 200 MG TABLET. The award has a potential value of $6,547.42 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is not set aside for any specific...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of the pharmaceutical product TABRECTA 200 MG TABLET UU 56S, with a ceiling value of $13,094.84 and a period of performance through April 10, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $6,547.42 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of September 27, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFD89
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFD89, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, with an ultimate completion date of February 10, 2025 and a ceiling value of $28,856.12. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a for-profit organization and a registered vendor in the System for Award Management (SAM.gov), with a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, as well as a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to support military healthcare programs and other federal beneficiaries.

Generated 4/18/25, 2:10 PM